Delaware

  • December 10, 2025

    Wanted: Temporary US Attorney, No Experience Needed

    Frustrated by a string of court rulings disqualifying several of his U.S. attorney picks, President Donald Trump lamented recently that he might "just have to keep appointing people for three months and then just appoint another one, another one." Experts say the idea raises legal and practical issues.

  • December 09, 2025

    Suns Seek $250M Capital Call Confirmation Amid Buyout Row

    The majority owner of the NBA's Phoenix Suns on Tuesday maintained that a $250 million capital call and a subsequent additional funding round this summer were properly issued under the LLC agreement, amid two minority owners' allegations of mismanagement in Delaware's Chancery Court.

  • December 09, 2025

    Tyson Seeks Del. Toss Of Suit For Poultry Growing Docs

    An attorney for a Tyson Foods Inc. stockholder told a Delaware magistrate in Chancery on Monday that records and sources spanning years support allegations of mismanagement and animal abuse and cruelty in poultry production, justifying wider document access.

  • December 09, 2025

    AmTrust Says Insurer Must Cover Securities Suit Losses

    A British insurance company wrongfully denied excess directors and officers coverage for underlying securities fraud litigation, AmTrust says in a suit filed in New York federal court Monday, saying the insurer must provide coverage since its primary policy and other excess policies have already been exhausted.

  • December 09, 2025

    NJ Slams Town's Bid To 'Unilaterally Rewrite' PFAS Deal

    New Jersey has slammed a bid by Carneys Point Township to intervene in the state's federal suit against Chemours and other companies over PFAS contamination, saying the township shouldn't be allowed to "rewrite" the terms of the deal.

  • December 09, 2025

    Del. Justices Uphold Contract Bar On CityMD Merger Claims

    The Delaware Supreme Court Tuesday affirmed the Chancery Court's dismissal of minority investors' claims tied to the 2023 merger of urgent care operator CityMD and Summit Health with Walgreens-controlled VillageMD, siding with private equity group Warburg Pincus and holding that the dispute is governed by contract rather than fiduciary-duty principles.

  • December 09, 2025

    Co-Founder Gave Up Stock Rights, Weapons Co. Tells Chancery

    Armaments Research Co. Inc., a weapons analytics company that uses AI, told the Delaware Chancery Court on Tuesday that its co-founder relinquished the contractual rights he now seeks to enforce over the valuation of his repurchased shares.

  • December 09, 2025

    3rd Circ. Won't Let Post-Gazette Duck Benefits Injunction

    A Third Circuit panel is standing by its decision to let an injunction against the Pittsburgh Post-Gazette remain active while the newspaper appeals, saying it won't reconsider its Nov. 24 refusal to stay an injunction requiring the paper to restore its workers' pre-2020 benefits.

  • December 08, 2025

    Trump's 'Unlawful' Freeze Of Wind Projects Gets Blocked

    A Massachusetts federal judge Monday blocked President Donald Trump's executive order indefinitely pausing permits for wind farm projects, ruling that the order was arbitrary and capricious and contrary to the law.

  • December 08, 2025

    Trump SPAC's Ex-CEO Seeks $50K Daily Sanctions In Fee Row

    A former CEO of Donald Trump-tied blank check company Digital World Acquisition Corp. has urged the Delaware Chancery Court to impose a $50,000-per-day sanction against the company for allegedly "throwing a tantrum" and refusing to pay roughly $2 million of a $2.9 million and growing legal fee advancement order in connection with litigation in Florida.

  • December 08, 2025

    1st Circ. Keeps Planned Parenthood Funding Ban In Place

    The First Circuit on Monday issued an administrative stay that temporarily keeps in place a ban on Medicaid funding for Planned Parenthood, pausing a lower court's ruling.

  • December 08, 2025

    Fed. Circ. Won't Revive Express Mobile's Patents Or $40M Win

    The Patent Trial and Appeal Board rightfully invalidated claims of three Express Mobile web-design patents, and a Delaware federal judge properly found Shopify didn't infringe additional, related patents, the Federal Circuit held Monday.

  • December 08, 2025

    Chancery Blocks Opt-Out In $32M Emisphere Settlement

    The Delaware Chancery Court on Monday signed off on a $32 million class settlement over Emisphere Technologies Inc.'s $1.8 billion sale to Novo Nordisk AS, rejecting Emisphere investor IsZo Capital LP's push to opt out and pursue its own claims and trimming the investors' fee request to a 23.5% cut of the fund.

  • December 08, 2025

    Judge Backs Cutting $800M In FTX Ch. 11 Claims

    A federal appellate judge has upheld the Delaware bankruptcy court's decision to pay out almost nothing on $800 million in claims against collapsed cryptocurrency exchange FTX, agreeing with the bankruptcy judge that the crypto assets tied to those claims were essentially worthless.

  • December 08, 2025

    Bernstein Litowitz Corp. Founder Returns To 'Stabilize' Group

    Bernstein Litowitz Berger & Grossmann LLP announced Monday that it has welcomed back a prominent shareholder lawyer to co-lead its corporate governance practice following the controversial departure of the group's former leader to launch a boutique firm.

  • December 08, 2025

    Del. Chancellor Finds Prince Estate Battle Will Play On

    Delaware's chancellor on Monday tossed some but not all amended counterclaims in a long-running battle among some relatives of the musician known as Prince and managing members of his estate, while saying a neutral party could help resolve the case.

  • December 08, 2025

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court delivered a busy first week of December, featuring commercial disputes, post-closing merger and acquisition battles and renewed scrutiny of fiduciary conduct ranging from oil and gas investments to healthcare acquisitions. 

  • December 08, 2025

    Justices Turn Down Machine Learning Patent Eligibility Case

    The U.S. Supreme Court on Monday left intact a decision that Recentive Analytics Inc. machine learning patents are invalid for claiming only abstract ideas, turning aside the company's argument in a dispute with Fox Corp. that the ruling effectively bars many artificial intelligence patents.

  • December 05, 2025

    Fed. Circ. Questions Whether Ingevity Can Duck $85M Verdict

    The Federal Circuit spent Friday morning debating whether Ingevity Corp.'s argument that it should be immune from an $85 million antitrust verdict holds water because the chemical and carbon product maker thought it was enforcing its patent rights, even though the jury said it was illegal tying.

  • December 05, 2025

    SG Urges Justices To Hear Hikma's 'Skinny Label' Patent Case

    The U.S. solicitor general on Friday urged the U.S. Supreme Court to hear Hikma Pharmaceuticals Inc.'s appeal of a decision reviving a patent suit involving its "skinny label" on a generic heart drug, saying the ruling puts the availability of lower-cost generics at risk.

  • December 05, 2025

    Constellation To Sell Power Plants For $26.6B Calpine Deal

    The U.S. Department of Justice said on Friday that enforcers have reached a deal allowing Constellation Energy Corp.'s $26.6 billion purchase of Calpine Corp. to move ahead, with the sale of power plants located in Delaware, Pennsylvania and Texas.

  • December 05, 2025

    9th Circ. Won't Unfreeze Trump Cuts To Student Mental Health

    The Ninth Circuit rejected the Trump administration's effort to undo a lower court's pause on federal funding reductions to K-12 mental health services, siding with a coalition of 16 states seeking to preserve programs established in the wake of high-profile school shootings.

  • December 05, 2025

    Judge Won't Lift Stay On Hopewell Drug Launch

    A Delaware federal judge has shot down Hopewell Pharma Ventures' bid to lift a regulatory stay on approval of its planned generic version of German drugmaker Merck's blockbuster multiple sclerosis drug Mavenclad.

  • December 05, 2025

    3rd Circ. Backs NJ In-State Rule For Medical Aid In Dying

    A Delaware woman with terminal cancer cannot end her life with medical assistance in New Jersey, the Third Circuit ruled Friday in a precedential opinion, finding that the Garden State residency requirement for medical aid in dying is restricted solely to New Jerseyans.

  • December 05, 2025

    3rd Circ. Clears Philadelphia Cops In Fatal Chase Crash

    The Third Circuit ruled Friday that Philadelphia police aren't liable for the death of a bystander struck by an alleged drug dealer fleeing the cops, reasoning in a precedential decision that the officers didn't intend to harm. 

Expert Analysis

  • Maintaining Legal Compliance For GenAI In Life Sciences

    Author Photo

    As companies continue to implement generative artificial intelligence to enhance all phases of drug discovery, they must remain mindful of legal, regulatory and practical considerations as best practices in this space emerge and evolve, say attorneys at Sullivan & Cromwell.

  • Series

    Teaching Business Law Makes Me A Better Lawyer

    Author Photo

    Teaching business law to college students has rekindled my sense of purpose as a lawyer — I am more mindful of the importance of the rule of law and the benefits of our common law system, which helps me maintain a clearer perspective on work, says David Feldman at Feldman Legal Advisors.

  • Navigating The Expanding Frontier Of Premerger Notice Laws

    Author Photo

    Washington's newly enacted law requiring premerger notification to state enforcers builds upon a growing trend of state scrutiny into transactions in the healthcare sector and beyond, and may inspire other states to enact similar legislation, say attorneys at Simpson Thacher.

  • Series

    Law School's Missed Lessons: Mastering Discovery

    Author Photo

    The discovery process and the rules that govern it are often absent from law school curricula, but developing a solid grasp of the particulars can give any new attorney a leg up in their practice, says Jordan Davies at Knowles Gallant.

  • Maneuvering The Weeds Of Cannabis Vertical Integration

    Author Photo

    The conversation around vertical integration has taken on new urgency as the cannabis market expands, despite federal reform remaining a distant dream, so the best strategy for cannabis operators is to approach vertical integration on a state-by-state basis, say attorneys at Sweetspot Brands.

  • Patent Takeaways In Fed. Circ.'s 1st Machine Learning Ruling

    Author Photo

    The Federal Circuit’s recent decision in Recentive Analytics v. Fox, a case of first impression affirming the invalidity of patents that applied general machine learning methods to conventional tasks, serves as a cautionary guide for patent practitioners navigating the complexities of machine learning inventions, say attorneys at Foley & Lardner.

  • Series

    Playing Guitar Makes Me A Better Lawyer

    Author Photo

    Being a lawyer not only requires logic and hard work, but also belief, emotion, situational awareness and lots of natural energy — playing guitar enhances all of these qualities, increasing my capacity to do my best work, says Kosta Stojilkovic at Wilkinson Stekloff.

  • Crisis Management Lessons From The Parenting Playbook

    Author Photo

    The parenting skills we use to help our kids through challenges — like rehearsing for stressful situations, modeling confidence and taking time to reset our emotions — can also teach us the fundamentals of leading clients through a corporate crisis, say Deborah Solmor at the Wisconsin Alumni Research Foundation and Cara Peterman at Alston & Bird.

  • Series

    Adapting To Private Practice: From NY Fed To BigLaw

    Author Photo

    While the move to private practice brings a learning curve, it also brings chances to learn new skills and grow your network, requiring a clear understanding of how your skills can complement and contribute to a firm's existing practice, and where you can add new value, says Meghann Donahue at Covington.

  • Top 3 Litigation Finance Deal-Killers, And How To Avoid Them

    Author Photo

    Like all transactions, litigation finance deals can sometimes collapse, but understanding the most common reasons for failure, including a lack of trust or a misunderstanding of deal terms, can help both parties avoid problems, say Rebecca Berrebi at Avenue 33 and Boris Ziser at Schulte Roth.

  • How Attys Can Use A Therapy Model To Help Triggered Clients

    Author Photo

    Attorneys can lean on key principles from a psychotherapeutic paradigm known as the "Internal Family Systems" model to help manage triggered clients and get settlement negotiations back on track, says Jennifer Gibbs at Zelle.

  • Opinion

    Third-Party Funding Transparency Is Key In Patent Suits

    Author Photo

    Third-party litigation funding is a growing industry that could benefit from enhanced disclosure standards to ensure transparency, as challenges in obtaining discovery of such funding can complicate patent litigation against nonpracticing entities, say attorneys at Skadden.

  • 3 Steps For In-House Counsel To Assess Litigation Claims

    Author Photo

    Before a potential economic downturn, in-house attorneys should investigate whether their company is sitting on hidden litigation claims that could unlock large recoveries to help the business withstand tough times, says Will Burgess at Hilgers Graben.

  • Series

    Teaching College Students Makes Me A Better Lawyer

    Author Photo

    Serving as an adjunct college professor has taught me the importance of building rapport, communicating effectively, and persuading individuals to critically analyze the difference between what they think and what they know — principles that have helped to improve my practice of law, says Sheria Clarke at Nelson Mullins.

  • Series

    Adapting To Private Practice: From DOJ Enviro To Mid-Law

    Author Photo

    Practitioners leaving a longtime government role for private practice — as when I departed the U.S. Department of Justice’s environmental enforcement division — should prioritize finding a firm that shares their principles, values their experience and will invest in their transition, says John Cruden at Beveridge & Diamond.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Delaware archive.